Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Published Online: 2017-09-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Andrew Hill•Gregory A Maglinte•Heinz-Josef Lenz•Jayesh Desai•Jean-Marie Ledeine•Joseph L Leach•Michael A Morse•Michael Axelson•Michael J Overman•Monica V Goldberg•Ray McDermott•Rebecca A Moss•Sara Lonardi•Scott Kopetz•Thierry André•Z Alexander Cao
